Our finding that NUMB alterations are associated with improved survival (92% vs. 73% at 100 months) aligns with this literature and suggests that NUMB may be a key molecular mediator of the protective effects observed in adenomyosis-associated endometrial pathology. This evidence concerns the gene NUMB and adenomyosis.